Stock MRK MERCK & CO., INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Merck & Co., Inc. Swiss Exchange

Equities

MRK

US58933Y1055

Delayed Swiss Exchange
Other stock markets
 16:36:38 05/12/2022 GMT 		5-day change 1st Jan Change
400 CHF +388.82% Intraday chart for Merck & Co., Inc. -.--% -.--%
06-28 Merck: positive opinion for Winrevair in Europe CF
06-28 Merck Gets CHMP Backing of Winrevair in Pulmonary Arterial Hypertension DJ

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Merck Says European Medicines Agency's Committee Recommends Approval of Heart Disease Drug Winrevair
MT
Merck Receives Positive EU CHMP Opinion for WINREVAIR (Sotatercept) in Pulmonary Arterial Hypertension
CI
EMA Says CHMP Gave Positive Opinion For mResvia RSV mRNA Vaccine For Prevention In Adults 60 Years And Older
RE
CDC?S ACIP Unanimously Recommends Merck?s CAPVAXIVE? (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults
CI
US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug
RE
Aqilion Announces the Termination of the Licensing and Collaboration Agreement with Merck for the Joint Development of the TAK1 Programme Taking Aim at Chronic Inflammation
CI
Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer
CI
Merck: US approval for canine flu vaccine
CF
Merck's Animal Health Unit Says USDA Approves Dog Flu Vaccine
MT
China grants license to Merck's KEYTRUDA for stomach cancer treatment
RE
Global markets live: Shell, UBS, Boeing, Berkshire Hathaway, Exxon...
Our Logo
Big tech still runs the show
Our Logo
Sector Update: Health Care Stocks Flat to Lower Premarket Tuesday
MT
Merck Receives FDA Approval for Capvaxive, Triggers $2 Million Payment for Ligand Pharmaceuticals
MT
US FDA approves Merck's pneumococcal vaccine for adults
RE
Merck Announces U.S. FDA Approves Capvaxive (Pneumococcal 21-Valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults
CI
Merck Announces FDA Approves Merck's Keytruda (Pembrolizumab) Plus Carboplatin and Paclitaxel as Treatment for Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma
CI
Ex-dividend day
FA
High-risk health workers can get routine Ebola vaccine, Gavi says
RE
AbbVie inks immune disorder drug licensing deal with China's FutureGen
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MRK Stock
  4. MRK Stock
  5. News Merck & Co., Inc.
  6. Highlights